Krka d. d
Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company's prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolis… Read more
Krka d. d (KRK) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.056x
Based on the latest financial reports, Krka d. d (KRK) has a cash flow conversion efficiency ratio of 0.056x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł128.16 Million) by net assets (zł2.31 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Krka d. d - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Krka d. d's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Krka d. d Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Krka d. d ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Worley Limited
PINK:WYGPF
|
0.080x |
|
Kodiak Gas Services, Inc.
NYSE:KGS
|
0.090x |
|
SFS Group AG
SW:SFSN
|
0.119x |
|
TECHNIP ENERGIES EO -01
F:68F
|
N/A |
|
HMM Co Ltd
KO:011200
|
0.041x |
|
RIOT PLATFORMS DL-001
F:AP4N
|
N/A |
|
Vista Oil & Gas S.A.B. de C.V
PINK:VSOGF
|
0.126x |
|
ELF Beauty Inc
NYSE:ELF
|
0.051x |
Annual Cash Flow Conversion Efficiency for Krka d. d (2010–2024)
The table below shows the annual cash flow conversion efficiency of Krka d. d from 2010 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | zł2.24 Billion | zł360.93 Million | 0.161x | +54.85% |
| 2023-12-31 | zł2.18 Billion | zł227.25 Million | 0.104x | -52.37% |
| 2022-12-31 | zł2.14 Billion | zł467.65 Million | 0.219x | +8.69% |
| 2021-12-31 | zł1.92 Billion | zł386.10 Million | 0.201x | -2.30% |
| 2020-12-31 | zł1.75 Billion | zł360.76 Million | 0.206x | -1.75% |
| 2019-12-31 | zł1.67 Billion | zł349.52 Million | 0.210x | +11.35% |
| 2018-12-31 | zł1.54 Billion | zł289.95 Million | 0.188x | +22.92% |
| 2017-12-31 | zł1.49 Billion | zł227.83 Million | 0.153x | +3.61% |
| 2016-12-31 | zł1.44 Billion | zł213.49 Million | 0.148x | -25.23% |
| 2015-12-31 | zł1.41 Billion | zł277.94 Million | 0.198x | +56.41% |
| 2014-12-31 | zł1.35 Billion | zł170.87 Million | 0.126x | -44.37% |
| 2013-12-31 | zł1.33 Billion | zł302.75 Million | 0.227x | +1.26% |
| 2012-12-31 | zł1.24 Billion | zł278.33 Million | 0.224x | +3.51% |
| 2011-12-31 | zł1.14 Billion | zł247.06 Million | 0.217x | +25.79% |
| 2010-12-31 | zł1.05 Billion | zł181.52 Million | 0.172x | -- |